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	 Monoammonium	 salt	 of	 12‐tungstophosphoric	 acid	 [(NH4)H2PW12O40]	 catalyst	was	 used	 for
the	synthesis	of	biologically	important	quinoxaline	derivatives	in	excellent	yields	from	various
aromatic	 1,2‐dicarbonyl	 and	 1,2‐diamines.	 The	 methodology	 has	 the	 advantages	 of	 mild
reaction	 conditions	 with	 simple	 workup	 procedure,	 even	 for	 the	 synthesis	 of	 quinoxaline
derivatives	from	sterically	hindered	diamine.	
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1.	Introduction	
	
Quinoxalines	 and	 its	 derivatives	 are	 an	 important	 class	 of	
benzoheterocycles	 [1,2]	 displaying	 a	 broad	 spectrum	 of	
biological	activities	 [3‐6]	 includes	antiviral,	 antibacterial,	 anti‐
inflammatory	 etc.	 They	 have	 also	 found	 applications	 as	 dyes	
[7,8]	 and	 building	 blocks	 in	 the	 synthesis	 of	 organic	 semi	
conductors	[9,10].	A	number	of	synthetic	strategies	have	been	
developed	 for	 preparation	 of	 substituted	 quinoxalines	 [11].	
Most	common	method	relies	on	the	condensation	of	an	aryl	1,2‐
diamine	with	1,2‐dicarbonyl	compounds	in	refluxing	ethanol	or	
acetic	 acid	 for	 2‐12	 h	 and	 this	 typically	 gives	 up	 to	 70‐80%	
yields.	
Progresses	 has	 been	 made	 and	 can	 be	 noted	 in	 the	
literatures	 for	 the	 synthesis	 of	 quinoxaline	 derivatives	
compounds,	 such	 as	 the	 Bi‐catalyzed	 oxidative	 coupling	
reaction	 [12],	 via	 a	 tandem	 oxidation	 process	 [13‐15]	 using	
Pd(OAc)2	or	RuCl2‐(PPh3)3‐TEMPO	and	MnO2,	heteroannulation	
of	 nitroketene	 N,S‐arylaminoacetals	 with	 POCl3	 [16],	 a	 solid‐
phase	synthesis	on	SynphaseTM	Lanterns	[17],	cyclization	of	‐
arylimino	 oximes	 compounds	 under	 refluxing	 condition	 in	
acetic	 anhydride	 [18],	 the	 condensation	 of	 a	 1,2‐phenylene‐
diamines	and	1,2‐dicarbonyl	compounds	in	MeOH/AcOH	under	
microwave	irradiation	[19],	and	the	molecular	iodine	catalyzed	
cyclocondensation	 reaction	 in	 DMSO	 and	 CH3CN	 [20],	
CuSO4.5H2O	 catalyzed	 cyclocondensation	 reaction	 in	 water,	
Zn[(L)proline]	 catalyzed	 cyclocondensation	 reaction	 in	 HOAc	
[21,22]	and	polyaniline‐sulfate	salt	[23]	catalyzed	condensation	
reactions	 etc.,	 and	 very	 recently	 Dong	 et	 al.	 reported	 the	
synthesis	 of	 quinoxaline	derivatives	 catalyzed	by	 task‐specific	
ionic	 liquids	 [24].	 However,	most	 of	 the	 traditional	 processes	
suffer	from	several	disadvantages,	such	as	pollution,	high	cost,	
poor	 chemical	 yields,	 longer	 reaction	 time,	 and	 tedious	work‐
up	 procedures,	 which	 limit	 their	 use	 under	 the	 aspect	 of	
environmentally	benign	processes.	Despite	remarkable	efforts,	
the	 development	 of	 an	 effective	 method	 for	 the	 synthesis	 of	
quinoxalines	is	still	an	important	challenge.	
Keggin	 type	 heteropoly	 acids	 (HPAs)	 have	 gained	 lot	 of	
attention	 due	 to	 their	 economical	 and	 environmental	
advantages	for	both	academic	and	industrial	applications.	They	
are	useful	as	acid	and	oxidation	catalysts	for	various	reactions	
since	 their	 catalytic	 features	 can	 be	 varied	 at	molecular	 level	
[25‐27].	 The	 most	 commonly	 used	 heteropolyacid	 is	 the	
dodecatungsto	 phosphoric	 acid	 (12‐TPA).	 However,	 the	 main	
disadvantage	 with	 the	 usage	 of	 acid	 form	 of	 heteropoly	
compounds	is	their	solubility	in	water	and	polar	solvents.	This	
problem	can	be	overcome	by	converting	it	into	its	salt,	like	the	
ammonium	 salt.	 We	 have	 developed	 heterogeneous	 TPA	
catalyst	by	partial	proton‐exchange	with	ammonium	carbonate	
to	result	water	insoluble	catalyst	namely	monoammonium	salt	
of	 12‐tungstophosphoric	 acid	 and	was	 employed	 for	 different	
applications	[28‐31].	In	continuation	to	our	previous	work,	we	
report	herein	a	simple	and	convenient	method	for	the	synthesis	
of	quinoxalines	derivatives	 in	 good	yields	 (85‐98%)	 from	1,2‐
phenylenediamine	 and	 benzil	 diketone	 (Scheme	 1)	 by	
employing	monoammonium	salt	of	12‐tungstophosphoric	acid	
as	 heteropoly	 acid	 catalyst.	 The	 advantage	 of	 the	 present	
catalyst	is	that	it	does	not	require	any	additives	or	promoters.	
Furthermore,	 the	 preparation	 of	 the	 catalyst	 is	 very	 simple,	
inexpensive	 and	 reusable	 without	 any	 loss	 of	 activity.	
Monoammonium	 salt	 of	 12‐TPA	 has	 excellent	 catalytic	
properties	with	good	selectivity	and	reusability	[28].	
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Scheme	1	
	
	
2.	Experimental	
	
2.1.	Materials	and	methods	
	
All	 the	 commercial	 reagents	 and	 solvents	 were	 used	
without	 further	 purification	 unless	 otherwise	 stated.	 1H	 NMR	
spectra	were	recorded	a	BRUKER	AMX	300‐MHz	spectrometer	
using	TMS	as	an	internal	standard.	IR	spectra	were	recorded	on	
Perkin	 FT‐IR	 spectrometer.	 GC	 analysis	 was	 performed	 using	
Agilent	 6850	 Series	 Gas	 Chromatograph	 equipped	 with	 FID	
detector.	 GC‐MS	 analysis	was	 performed	using	Agilent	 6890N	
Gas	 Chromatograph	 connected	 to	 Agilent	 5973	 Mass	
Spectrometer	 at	 70	 eV	 (m/z,	 50‐600;	 source	 at	 230	 oC	 and	
quadruple	at	150	oC)	 in	 the	EI	mode	with	a	HP‐5	ms	capillary	
column	 (30	 m	 x	 0.25	 mm;	 0.25	 µm).	 All	 the	 reactions	 were	
monitored	 by	 thin	 layer	 chromatography	 performed	 on	
precoated	silicagel	60F254	plates	(Merck).	
	
2.2.	Procedure	for	the	preparation	of	the	catalyst	
	
Monoammonium	 salt	 of	 12‐tungstophosphoric	 acid	 was	
prepared	by	simple	ion	exchange	of	12‐tungstophosphoric	acid	
with	 a	 required	 amount	 of	 ammonium	 carbonate	 in	 aqueous	
medium	 [28].	 Ammonium	 carbonate	 solution	 (0.167	 g,	 0.17	
mmol,	 dissolved	 in	10	mL	 of	 distilled	water)	was	 added	drop	
wise	 to	an	aqueous	solution	of	12‐tungstophosphoric	acid	(10	
g,	 0.35	mmol,	 dissolved	 in	 50	mL	 of	 distilled	water)	 at	 80	 oC	
under	stirring.	The	reaction	mixture	was	stirred	at	80	oC	for	3	h,	
evaporated	 to	 dryness,	 and	 kept	 overnight	 at	 120	 oC.	 The	
catalyst	 was	 calcined	 in	 air	 at	 350	 oC	 for	 4	 h	 to	 obtain	
monoammonium	salt	of	12‐tungsto‐phosphoric	acid.	Yield:	9.25	
g,	92%.	
	
2.3.	General	procedure	for	the	synthesis	of	quinoxalines	
	
A	 mixture	 of	 1,2	 dicarbonyl	 (1	 mmol)	 and	 aromatic	 1,2	
diamine	(1	mmol)	 in	1,2‐dichloroethane	(5	mL)	was	stirred	at	
room	 temperature	 in	presence	of	monoammonium	salt	 of	12‐
tungsto	 phosphoric	 acid	 catalyst	 (5	wt.%	with	 respect	 to	 1,2‐
dicarbonyl).	The	reaction	was	monitored	by	TLC.	The	reaction	
mixture	was	filtered	to	recover	the	catalyst	and	the	filtrate	was	
concentrated	under	vacuum.	The	crude	product	was	purified	by	
silica	 gel	 column	 chromatography	 (eluent‐95:5	 hexane‐ethyl	
acetate)	 to	 give	 the	pure	product.	 The	 recovered	 catalyst	was	
dried	 in	 oven	 at	 110	 oC	 for	 2	 h	 and	 reused	 for	 the	 next	 run.	
Representative	 examples	 of	 synthesized	 quinoxaline	
compounds:	
2,3‐Diphenyl	 quinoxaline	 (3a):	 FT‐IR	 (KBr,	 cm‐1):	 3059,	
1478,	1345,	765.	1H	NMR	(300	MHz,	CDCl3,	δ,	ppm):	7.39‐7.42	
(m,	6H),	7.55	(m,	4H),	7.79	(dd,	J	=	6.3	Hz,	2H),	8.2	(dd,	J	=	6.30	
Hz,	2H).	GC‐MS	(EI,	m/z):	282	(M+).	
6‐Methyl‐2,3diphenylquinoxaline	 (3d):	 FT‐IR	 (KBr,	 cm‐1):	
3056,	 1660,	 1480,	 1208,	 756.	 1H	 NMR	 (300	 MHz,	 CDCl3,	 δ,	
ppm):	1.6	(s,	3H),	7.35‐7.44	(m,	6H),	7.56	(m,	4H),	7.63	(dd,	J	=	
8.56	Hz,	1H),	7.96	(d,	J	=	8.5	Hz,	1H),	8.1	(d,	J	=	8.5	Hz,	1H).	GC‐
MS	(EI,	m/z):	296	(M+).	
2,3‐Bis(4‐methoxy‐phenyl)quinoxaline	 (3f):	 FT‐IR	 (KBr,	 cm‐
1):	 3003,	 2958	 ,	 1608,	 1345,	 1513,	 1251,	 1029,	 757.	 1H	NMR	
(300	MHz,	CDCl3,	δ,	ppm):	3.81	(s,	6H),	6.85	(d,	J	=	7.9	Hz,	4H),	
7.47	 (d,	 J	 =	8.5	Hz,	4H),	7.68	 (m,	2H),	8.1	 (m,	2H).	GC‐MS	 (EI,	
m/z):	342	(M+).	
2,3‐Bis(4‐methyl‐phenyl)quinoxaline	(3i):	FT‐IR	(KBr,	cm‐1):	
3031,	 1613,	 1592,	 1342,1216,1057,	 822,	 756.	 1H	 NMR	 (300	
MHz,	 CDCl3,	 δ,	 ppm):	 2.4	 (s,	 6H),	 7.39‐7.42	 (m,	 4H),	 7.55	 (m,	
4H),	7.79	(dd,	J	=	6.30	Hz,	2H),	8.2	(dd,	J	=	6.30	Hz,	2H).	GC‐MS	
(EI,	m/z):	310	(M+).	
2,3‐Bis(4‐methyl‐phenyl)6‐nitroquinoxaline	 (3k):	 FT‐IR	
(KBr,	 cm‐1):	3003,	2931,	1660,	1592,	1210,	1604,	1510,	1345,	
1057,	876.	1H	NMR	(300	MHz,	CDCl3,	δ,	ppm):	2.4	(s,	6H),	7.10	
(m,	4H),	7.56	(m,	4H),	8.24	(d,	J	=	9.1	Hz,	1H),	8.49	(dd,	J	=	9.1	
Hz,	1H),	9.1	(d,	J	=	8.1	Hz,	1H).	GC‐MS	(EI,	m/z):	355	(M+).	
2,3‐Di	 (furan‐2‐yl)quinoxaline	 (3m):	 FT‐IR	 (KBr,	 cm‐1):	
3120,	1568,	1522,	1484,	1345,	750.	1H	NMR	(300	MHz,	CDCl3,	δ,	
ppm):	6.6	(d,	2H),	6.85	(dd,	J	=	6.3	Hz,	2H),	7.68	(d,	J	=	6.3	Hz,	
2H),	7.72	(dd,	J	=	6.3	Hz,	2H),	8.20	(d,	J	=	9.2	Hz,	1H),	8.47	(dd,	J	
=	9.2.1	Hz,	1H),	8.98	(s,	1H).	GC‐MS	(EI,	m/z):	307	(M+).	
	
Table	1.	Effect	of	solvents	for	the	synthesis	of	quinoxaline	derivativesa.	
Entry Solvents Time	(min)	 Yieldb	(%)
1	 Acetonitrile	 40	 96	
2 Dichloromethane 30	 97
3	 Dichloroethane	 15	 98	
4	 Ethyl	acetate	 45	 94	
5	 Toluene	 45	 93	
6 Hexane 45	 94
7 Methanol 45	 89
8 Ethanol 45	 92
9 Diethyl	ether 45	 91
10 Tetrahydrofuran 60	 90
a	 1,2‐Phenylenediamine	 (1	 mmol),	 Benzil	 (1	 mmol),	 Catalyst	 (5	 wt.%	 of	
benzil),	Dichloroethane	(5	mL),	Room	temperature.		
b	Isolated	yields.	
	
3.	Results	and	discussion		
	
Initially	 the	 reaction	 was	 conducted	 with	 benzil	 and	 1,2‐
phenylenediamine	 (1:1	 mmol)	 in	 acetonitrile	 at	 room	
temperature	without	using	catalyst	and	obtained	2,3‐diphenyl	
quinoxaline	 in	 very	 low	 yield	 even	 after	 24	 h	 of	 reaction,	
whereas	 use	 of	 the	 monoammonium	 salt	 of	 12‐TPA	 catalyst	
afforded	 the	 product	 in	 quantitative	 yield	 within	 40	 min.	
Different	 solvents	with	 various	polarity	were	 screened	 (Table	
1)	for	the	condensation	reaction	in	the	presence	of	catalyst	and	
found	 that	 all	 the	 solvents	 studied	 afforded	 the	 products	 in	
excellent	yields	with	a	slight	variation	in	reaction	period	(15‐60	
min).	Among	all	 these	solvents,	dichloroethane	(Table	1,	entry	
3)	was	 found	 to	 be	 the	 best	 solvent	 of	 choice	which	 not	 only	
afforded	the	product	in	99%	yield,	but	also	with	higher	reaction	
rate	(15	min).	
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Table	2.	Synthesis	of	quinoxaline	derivatives	catalyzed	by	monoammonium	salt	of	12‐TPAa.	
Entry	 Qunoxaline	 Reaction	time	(min) Yield	b	(%) Entry	 Qunoxaline	 Reaction	time	(min)	 Yield	b	(%)
1	
	
3a	
10	 98 8
N
N
H3CO
H3CO
NO2
3h
30	 90
2	
	
3b	
20	 92	 9	
	
3i
30	 90	
3	
	
3c	
30	 90	 10	
N
N
H3C
H3C
CH3
	
3j	
10	 86	
4	
N
N
CH3
	
3d	
15	 93 11
N
N
H3C
H3C
NO2
	
3k	
30	 85
5	
	
3e	
10	 94 12
	
3l	
10	 92
6	
	
3f	
10	 92 13
N
N
NO2
O
O
	
3m	
30	 93
7	
	
3g	
15	 91 14
	
3n	
15	 34
a	Diamine	(1	mmol),	1,2‐dicarbonyl	compound	(1	mmol),	Catalyst	(5	wt.%	of	substrate),	Dichloroethane	(5	mL),	Room	temperature.	
b	Isolated	yields.	
	
	
In	 order	 to	 evaluate	 the	 efficiency	 of	 this	 methodology,	
condensation	of	various	1,2‐diketone	compounds	with	different	
substituted	1,2‐phenylenediamines	were	carried	out	(Table	2)	
by	 employing	 the	 catalyst	 in	 dichloroethane	 solvent	 at	 room	
temperature	to	obtain	the	corresponding	quinoxalines	3a‐n	 in	
good	yields	(85‐98%)	and	the	results	are	summarized	in	Table	
2.	 Condensation	 of	 1,2‐phenylenediamine	 with	 benzil	 gave	
quinoxaline	 3a	 in	 98%	 yield	 within	 10	min.	 The	 presence	 of	
electron	 donating	 substituents	 in	 the	 amine	 part,	 increased	
yields	were	obtained	(3d	and	3e)	within	10‐15	min	compared	
to	 electron	 withdrawing	 substituents	 (3b	 and	 3c)	 inspite	 of	
more	 reaction	 period	 of	 20‐30	 min.	 On	 the	 other	 hand,	
electron‐donating	substituents	on	the	aromatic	ring	attached	to	
diketones	gave	the	lowest	yield	among	all	the	studied	diketone	
substrates	 (Table	 2,	 entry	 10	 and	 11).	 Heterocyclic	 substrate	
furoin	 with	 4‐methyl‐1,2‐phenylenediamine	 gave	 94%	 yield	
(Table	 2,	 entry	 14)	 in	 15	 min	 compared	 to	 4‐nitro‐1,2‐
phenylenediamine	 (Table	2,	 entry	13,	30	min),	 indicating	 that	
electron	 donating	methyl	 group	 in	 the	 diamines	 enhances	 its	
nucleophilicity.	Over	all	the	catalyst	showed	exceptionally	high	
activity	towards	this	reaction.	After	completion	of	the	reaction,	
the	 catalyst	 was	 separated	 by	 simple	 filtration	 and	 washed	
several	times	with	ethyl	acetate.	Later	the	catalyst	was	dried	in	
air	 oven	 at	 120	 C	 for	 1	 h	 and	 reused.	 The	 reusability	 of	 the	
catalyst	 was	 found	 to	 be	 effective	 up	 to	 three	 cycles	 without	
any	loss	in	the	activity.	All	the	products	were	characterized	by	
FT‐IR,	1H	NMR,	and	GC‐MS	analysis.	
	
4.	Conclusion	
	
In	 conclusion,	 we	 have	 demonstrated	 a	 very	 simple,	
efficient,	 clean,	 and	 practical	 method	 for	 the	 synthesis	 of	
various	 quinoxaline	 derivatives	 in	 good	 yields	 (85‐98%)	 by	
employing	 monoammonium	 salt	 of	 12‐TPA	 as	 an	 efficient	
catalyst	 in	 dichloethane	 as	 more	 suitable	 solvent.	 It	 is	
applicable	 to	 a	 wide	 range	 of	 structural	 types;	 moreover,	
preparation	 of	 maono	 ammonium	 salt	 of	 12‐TPA	 catalyst	 is	
simple,	and	it	is	non‐toxic,	inexpensive	and	reusable.	
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